140 related articles for article (PubMed ID: 3167855)
1. Activation of mouse macrophages by alkylglycerols, inflammation products of cancerous tissues.
Yamamoto N; St Claire DA; Homma S; Ngwenya BZ
Cancer Res; 1988 Nov; 48(21):6044-9. PubMed ID: 3167855
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D3 binding protein required for in vitro activation of macrophages after alkylglycerol treatment of mouse peritoneal cells.
Yamamoto N; Homma S; Haddad JG; Kowalski MA
Immunology; 1991 Nov; 74(3):420-4. PubMed ID: 1769691
[TBL] [Abstract][Full Text] [Related]
3. Activation process of macrophages after in vitro treatment of mouse lymphocytes with dodecylglycerol.
Homma S; Yamamoto N
Clin Exp Immunol; 1990 Feb; 79(2):307-13. PubMed ID: 2178824
[TBL] [Abstract][Full Text] [Related]
4. A serum factor for macrophage activation after in vitro dodecylglycerol treatment of mouse lymphocytes.
Homma S; Millman I; Yamamoto N
Immunol Cell Biol; 1990 Apr; 68 ( Pt 2)():137-42. PubMed ID: 1696561
[TBL] [Abstract][Full Text] [Related]
5. Conversion of vitamin D3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of beta-galactosidase of B cells and sialidase of T cells.
Yamamoto N; Kumashiro R
J Immunol; 1993 Sep; 151(5):2794-802. PubMed ID: 8360493
[TBL] [Abstract][Full Text] [Related]
6. Activation of mouse peritoneal macrophages by lysophospholipids and ether derivatives of neutral lipids and phospholipids.
Yamamoto N; Ngwenya BZ
Cancer Res; 1987 Apr; 47(8):2008-13. PubMed ID: 2950993
[TBL] [Abstract][Full Text] [Related]
7. The contribution of a serum component(s) modified by B cells to the mechanism for macrophage activation by liposomes.
Aramaki Y; Murai M; Tsuchiya S
Immunology; 1993 Oct; 80(2):253-8. PubMed ID: 8262553
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D3-binding protein as a precursor for macrophage activating factor in the inflammation-primed macrophage activation cascade in rats.
Yamamoto N; Naraparaju VR
Cell Immunol; 1996 Jun; 170(2):161-7. PubMed ID: 8660814
[TBL] [Abstract][Full Text] [Related]
9. A defect in the inflammation-primed macrophage-activation cascade in osteopetrotic rats.
Yamamoto N; Lindsay DD; Naraparaju VR; Ireland RA; Popoff SN
J Immunol; 1994 May; 152(10):5100-7. PubMed ID: 8176226
[TBL] [Abstract][Full Text] [Related]
10. Participation of serum proteins in the inflammation-primed activation of macrophages.
Yamamoto N; Willett NP; Lindsay DD
Inflammation; 1994 Jun; 18(3):311-22. PubMed ID: 8088927
[TBL] [Abstract][Full Text] [Related]
11. Contribution of lysophosphatidylcholine-treated nonadherent cells to mechanism of macrophage activation.
Ngwenya BZ; Yamamoto N
Proc Soc Exp Biol Med; 1990 Feb; 193(2):118-24. PubMed ID: 2300592
[TBL] [Abstract][Full Text] [Related]
12. Identification of the serum factor required for in vitro activation of macrophages. Role of vitamin D3-binding protein (group specific component, Gc) in lysophospholipid activation of mouse peritoneal macrophages.
Yamamoto N; Homma S; Millman I
J Immunol; 1991 Jul; 147(1):273-80. PubMed ID: 2051023
[TBL] [Abstract][Full Text] [Related]
13. Role of vitamin D3-binding protein in activation of mouse macrophages.
Yamamoto N; Naraparaju VR
J Immunol; 1996 Aug; 157(4):1744-9. PubMed ID: 8759764
[TBL] [Abstract][Full Text] [Related]
14. Macrophages as effector cells of protective immunity in murine schistosomiasis. VI. T cell-dependent, lymphokine-mediated, activation of macrophages in response to Schistosoma mansoni antigens.
James SL; Lazdins JK; Hieny S; Natovitz P
J Immunol; 1983 Sep; 131(3):1481-6. PubMed ID: 6350456
[TBL] [Abstract][Full Text] [Related]
15. Anti-neoplastic action of peritoneal macrophages following oral administration of ether analogues of lysophospholipids.
Ngwenya BZ; Fiavey NP; Mogashoa MM
Eur J Cancer; 1992; 28A(10):1637-42. PubMed ID: 1389479
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of macrophage Fc-dependent phagocytosis by resident thymocytes: effect of a unique heat-stable lymphokine.
Coleman DL; Root RK; Ryan JL
J Immunol; 1983 May; 130(5):2195-9. PubMed ID: 6339624
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of antibody production by lysophosphatidylcholine and alkylglycerol.
Ngwenya BZ; Foster DM
Proc Soc Exp Biol Med; 1991 Jan; 196(1):69-75. PubMed ID: 1984244
[TBL] [Abstract][Full Text] [Related]
18. Cellular and growth factor requirements for activation of human T lymphocytes by neuraminidase and galactose oxidase-treated lymphoid cells.
Lipkowitz S; Rubin AL; Stenzel KH; Novogrodsky A
J Immunol; 1983 Jun; 130(6):2702-7. PubMed ID: 6602177
[TBL] [Abstract][Full Text] [Related]
19. Activation of peritoneal macrophages by orally administered ether analogues of lysophospholipids.
Ngwenya BZ; Fiavey NP; Mogashoa MM
Proc Soc Exp Biol Med; 1991 May; 197(1):91-7. PubMed ID: 1850526
[TBL] [Abstract][Full Text] [Related]
20. T cell-macrophage cognate interaction in the activation of macrophage effector function by Th2 cells.
Stout RD; Suttles J
J Immunol; 1993 Jun; 150(12):5330-7. PubMed ID: 8515061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
